Oncopole, the FRQS Cancer Center, announces the winners of its 2022 Patient Priority competition – Investing in Transforming Oncology Care and Services in Quebec

Montreal and San DiegoAnd the June 13, 2022 / CNW Telbec / – Patient partners are at the heart of the four research projects that won 2e An edition of the “Patient Priority” competition from Oncopole – The Cancer Center of the Quebec Health Research Fund (FRQS). This competition consists of supporting research projects that aim to better support people with cancer in Quebec. In particular, by improving the course of care and services they receive in the field of cancer treatment.

This announcement comes on the occasion of the BIO International Conference to be held from 13-16 June San DiegoRepresentatives from Oncopole, the FRQS Cancer Center, the Department of Economics and Innovation (MEI), the Department of Health and Social Services (MSSS), and Merck Canada attended. The four teams will receive $200,000 from Oncopole, over two years, thanks to financial support from MEI and its co-founder, Merck Canada.

These innovative projects share the fact that they include patient partners on each of the research teams. They will be involved from the design of the project to its implementation in a clinical context, as well as its evaluation with the aim of extending it to other healthcare and health centers in Quebec. This competition is conducted in collaboration with the Quebec Health Education System Support Unit (SSA) and the MSSS Quebec Cancer Program.

Oncopole Patient Priority Program Recipients

PAROLE-Onco+: Peer support to improve the experience of patients with cancer

The context of the pandemic has highlighted the lack of emotional support for people with cancer. To better meet this need, the PAROLE-Onco+ project will provide patients with peer support workers – people who have lived with cancer – in order to support them and share their knowledge throughout the course of care and health services.

Led by Marie-Pascal Baume, Professor of Public Health at the University of Montreal, the PAROLE-Onco+ project will test a proven model of peer support with adults and children with different types of cancer (prostate, thyroid, gynecological, colorectal, lung, hematological, and breast), in Regional and urban contexts within the different structures (CHU, CISSS, CIUSSS).

plus mI Baume, the team consists of 23 research associates, including seven patient partners, attached to the University of Montreal, the university Lavalat University Sherbrooke And at HEC Montreal.

The eG2 intervention: a virtual speech therapy intervention for swallowing under the guidance of the patient’s partner

In people treated for head and neck cancer, chemotherapy is known to have serious side effects that lead to swallowing disorders or dysphagia. Directed by Mary Eve Katie, Professor in the Department of Oncology at the University of Quebec at Trois-Rivieres, the eG2 intervention consisted of evaluating the benefits of a virtual group speech therapy intervention model for the prevention of swallowing disorders in these patients treated with radiochemotherapy. In a specialized caring environment.

Halfway between group therapy and a support group, this telehealth approach allows patients to participate in weekly speech therapist-led meetings accompanied by the patient’s partner. These meetings aim to support them to better prevent complications related to dysphagia and thus improve their quality of life and quality of care.

This project is implemented in collaboration with eight co-researchers, including a patient partner, of the Center Hospitalier de l’Université de Montréal (CHUM).

Virtual reality and hypnosis to support multiple myeloma patients

Inspired by booming software, David OgisA professor in the Department of Anesthesiology and Pain Medicine at the University of Montreal, has developed a new support approach that combines virtual reality and hypnosis. Developed by clinicians, researchers, digital artists and patient partners in Cancer Remission, this new program will be validated with patients with multiple myeloma, one of the most aggressive types of blood cancers whose treatments cause negative effects.

during In this experiment, each patient will be accompanied by a speaker who takes the form of an avatar. He will provide individualized care aimed at providing patients with an experience that distracts them from their negative feelings and physical discomforts that they experience during stem cell transplantation.

research team David Ogis It consists of eleven research associates, including two patient partners, affiliated with the University of Montreal.

Project VIE: Towards Integrated Interventions for Pediatric Oncology Patients and Their Families

People who survive childhood cancer are more likely to develop major health problems in adulthood, such as cardiovascular disease, obesity, high blood pressure, or type 2 diabetes. Researcher Valerie Marcel, professor in the Department of Nutrition at the University of Montreal, so created A personalized program of early interventions that include nutrition, physical activity, and psychosocial support for pediatric patients newly diagnosed with cancer.

This “toolbox” for children treated in oncology and their families is also used to train health professionals in order to facilitate the development of interventions in other centers.

Ten co-researchers make up Valerie Marcel’s research team, including two patient partners, all affiliated with the University of Montreal, a university Laval And at the University of Sherbrooke.

A competition to transform oncology care and services

Thanks to the public-private partnership between the Ministry of Economy and Innovation and Merck Canada, Oncopole is able to support, through the Patient Priority competition, these four projects that will enable research teams to contribute to transforming cancer care and services.

“The research teams were able to draw on the life experience of people with cancer to design and implement their project, and we also drew on the expertise of patient partners when evaluating projects to ensure they were appropriate for the target population,” confirms Carol Gabet, Oncopole Director and Scientific Director of FRQS.

“We extend our sincere congratulations to the winners of the second edition of the Patient Priority Competition. As a founding member of the Oncopole Initiative, Merck Canada is very proud to continue year after year to support research projects that improve the experience of care and services, as well as the quality of life, for cancer patients and their families. We are deeply invested in developing research and partnerships that meet patients’ needs. This project demonstrates our commitment to our shared mission and vision: to save and improve lives.” Jennifer Chanexecutive director, health policy and foreign affairs, Merck Canada Inc.

About Oncopole, FRQS Cancer Center

FRQS’s Oncopole Cancer Center is the result of a unique approach to co-innovation, supporting research, innovation and investments to accelerate the fight against cancer, thanks to co-founder Merck Canada. Oncopole’s mission is to act as a catalyst for actions disseminated by the Quebec research and innovation ecosystem. It aims to position the county as a leader in this field. For more information visit oncopole.ca

About Merck

For more than 130 years, Merck, known as MSD outside the United States and Canada, has been lifelong inventing and producing medicines and vaccines for many of the world’s most devastating diseases to carry out its mission to save and improve lives. We demonstrate our commitment to patients and population health by improving access to healthcare through far-reaching policies, programs and partnerships. Today, Merck remains at the forefront of research to prevent and treat diseases that threaten humans and animals, including cancer and infectious diseases such as HIV, Ebola and emerging animal diseases. . For more information about our operations in Canada, visit www.merck.ca and follow us Youtube And on Twitter Tweet embed.

SOURCE Quebec Research Fund – Health

For more information: Call Maxime Dumais, Oncopole, 514231-9809, [email protected]



#Oncopole #FRQS #Cancer #Center #announces #winners #Patient #Priority #competition #Investing #Transforming #Oncology #Care #Services #Quebec

Leave a Comment

Your email address will not be published.